HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

aminobutane bisphosphonate

may be useful measure for controlling hypercalcemia in patients with carcinoma

Also Known As:

AButBP; aminobutane 1,1-diphosphonate; aminobutylidene diphosphonate

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Diphosphonates: 11565
      - aminobutane bisphosphonate: 3

Related Diseases

1.	Bone Resorption 07/01/1992 - "In a parallel study we have shown that intravenous administration of aminobutane bisphosphonate, a powerful inhibitor of bone resorption, produces similar decreases in serum calcium which were associated with significant increases in intact PTH. " 01/01/1991 - "Fibronectin release from cultured macrophages, derived from human blood monocytes, was measured during incubation of the cells with increasing concentrations of vitamin D3 metabolites or of aminobutane bisphosphonate (AHButBP) or dichloromethylene bisphosphonate (Cl2MBP), two powerful inhibitors of bone resorption. "
2.	Neoplasms (Cancer) 08/01/1987 - "The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy."
3.	Hypercalcemia (Milk Alkali Syndrome) 08/01/1987 - "54 patients with malignant hypercalcemia were treated with either dichloromethylene bisphosphonate (Cl2MBP) or aminobutane bisphosphonate (AHButBP). " 08/01/1987 - "The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy."

Related Drugs and Biologics

1.	Calcium
2.	Diphosphonates (Bisphosphonates)
3.	Fibronectins (Fibronectin)
4.	Cholecalciferol (Vitamin D3)

Related Therapies and Procedures

1.	Intravenous Administration